Reaktionsgleichung
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[N:9]3[CH:21]=[CH:20][N:19]=[C:10]3[S:11][C:12]3[CH:18]=[CH:17][CH:16]=[CH:15][C:13]=3[N:14]=2)[CH2:4][CH2:3]1.[Cl:22]C1C=CC=C(C(OO)=[O:30])C=1.Cl>C(Cl)Cl.CCOCC>[ClH:22].[CH3:1][N+:2]1([O-:30])[CH2:7][CH2:6][N:5]([C:8]2[N:9]3[CH:21]=[CH:20][N:19]=[C:10]3[S:11][C:12]3[CH:18]=[CH:17][CH:16]=[CH:15][C:13]=3[N:14]=2)[CH2:4][CH2:3]1Komponenten
6
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Reaktionsbedingungen
- Temperatur
- 0 °C
Versuchsvorschrift
To the solution of 88 mg of 5-(4-methylpiperazino)-imidazo[2,1-b][1,3,5]benzothiadiazepine in 1 ml of methylene chloride, 74 mg of m-chloroperbenzoic acid are added at 0° C. The mixture is stirred at 0° C. overnight; this is diluted with 1 ml of ether, one equivalent of ethereal hydrochloric acid solution is added and the resulting precipitate is collected. Recrystallization from methanol-ethyl acetate yields 5-(4-methyl-4-oxidopiperazino)-imidazo[2,1-b][1,3,5]benzothiadiazepine hydrochloride, melting at 155° with decomposition.
Aufarbeitung
- additionis added
- customthe resulting precipitate is collected
- customRecrystallization from methanol-ethyl acetate
Quellen und Nachweise
- ORD-Eintrag
- ord-bd76b2b5f6484aedb9e1051a75695721
- Quelldatensatz
- uspto-grants-1983_07
- Patentnummer
- US04391808
Verknüpfte Notizen
Wird geladen…